Recovery research fieldbook Evidence, not treatment advice
Recovery archive

Published recovery field note

HGH Fragment 176-191 | ≥99% Pure | Nationwide Peptides

Research-grade HGH Fragment 176-191, ≥99% purity by HPLC-MS testing. GMP-synthesized lyophilized peptide with CoA for adipose research. For Research Use Only.

Context first

Study findings do not automatically establish clinical benefit, safety, dosing, or suitability for an individual.

HGH Fragment 176-191 is a truncated peptide corresponding to amino acids 176-191 of the full-length human growth hormone (hGH) protein, first identified in the 1990s for its selective lipolytic properties independent of full hGH’s anabolic effects. This research-grade lyophilized formulation is synthesized under strict quality controls and provided with comprehensive analytical documentation, making it suitable for metabolic, oncology, and regenerative biology studies. For Research Use Only. Not for human use.

Key Scientific Specifications

High-purity HGH Fragment 176-191 (≥ 98% by HPLC, acetate salt form)

Verified 16-amino-acid sequence (Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe)

Lyophilized powder for optimal stability and solubility

Full Certificate of Analysis (COA) with HPLC, MS, and amino acid analysis

Manufactured in GMP-aligned, ISO-compliant facilities

Suitable for lipolytic pathway, adipose metabolism, and receptor-binding research

Research-Referenced Applications (Based on scientific literature; not therapeutic claims)

Selective stimulation of lipolysis and fat oxidation in adipose tissue models via beta-3 adrenergic receptor (ADRB3) agonism in preclinical settings

Potential modulation of glycogen synthase phosphatase and glucose metabolism in rodent muscle tissue models

Enhancement of drug delivery and cytotoxicity in cancer cell lines (e.g., MCF-7 breast cancer via receptor targeting) as referenced in peer-reviewed literature

Investigation of thermogenesis and energy expenditure pathways in experimental models without observed IGF-1 elevation in preclinical data

Exploration of mitochondrial uncoupling and AMPK phosphorylation for fatty acid oxidation in in-vitro and animal models

Synergistic effects in blends with GHRH analogs for metabolic and hormonal signaling studies in laboratory settings

Why Researchers Choose HGH Fragment 176-191

Precise C-terminal sequence mimicry (not full hGH or modified AOD9604)

Consistent solubility and bioactivity batch-to-batch

Transparent analytical data (HPLC, MS, purity >98%)

Used in metabolic endocrinology, oncology, and peptide-biotechnology laboratory research

Competitive research pricing with bulk options

Connected topics

Follow this recovery question